Delivery Order SPE2DR25D1116-SPE2DR26FTF5W
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 6, 2025, for the supply of Ondansetron ODT 8 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with a ceiling value of $1,808.64, with an ultimate completion date of December 8, 2025. The contract carries no set-aside designation and represents a competitively awarded transaction. Performance will be executed from AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Ondansetron ODT 8 mg tablets in quantities of 30 units, with a contract ceiling value of $7,608.34 and an ultimate completion date of December 2, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award to the pharmaceutical distributor's Conshohocken, Pennsylvania corporate office. The delivery order is issued under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order valued at $1,618.73 to AmerisourceBergen Drug Corp for Ondansetron ODT 8 mg tablets (30-count units) on December 4, 2025, with completion scheduled for December 5, 2025. The award is a firm fixed price delivery order with no set-aside designation, indicating competitive selection. Performance will be executed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Ondansetron ODT 8 mg tablets in quantities of 30 units, with a ceiling value of $7,625.49. This competitively awarded, non-set-aside order features firm fixed pricing and is scheduled for completion by November 5, 2025. The place of performance is the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a routine...
- The Defense Logistics Agency awarded a delivery order valued at $19,783.48 to AmerisourceBergen Drug Corp on June 25, 2025, for the supply of Ondansetron ODT 8 mg tablets (30-count units). The contract is a firm fixed-price delivery order with a completion date of June 26, 2025, and is being performed at the contractor's location in Conshohocken, Pennsylvania. This award carries no set-aside designation and was competitively awarded through the federal procurement process. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $35,913.34 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 8 mg tablets (30-count) on August 4, 2025, with an ultimate completion date of August 5, 2025. This competitively awarded, firm fixed-price delivery order was issued with no set-aside designation and specifies Conshohocken, Pennsylvania as the place of performance, which aligns with the contractor's corporate headquarters location. The award represents a...
- The Defense Logistics Agency awarded a $7,527.37 delivery order to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 8 mg tablets (30-count units) with an ultimate completion date of July 23, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen is a major pharmaceutical distributor and critical federal healthcare vendor that...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 7, 2025, for the supply of Ondansetron ODT 8 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with a ceiling value of $14,188.55 and an ultimate completion date of October 8, 2025. The contract is not set-aside and was competitively awarded. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Ondansetron ODT 4 mg tablets in a quantity of 30 units. This firm fixed price delivery order, valued at $10,217.96, represents a non-set-aside competitive award with an ultimate completion date of December 4, 2025. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $7,553.06 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count) with an ultimate completion date of December 9, 2025. This is a firm fixed price delivery order with no set-aside designation, reflecting competitive award criteria. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary distribution operations. This...
- SPE2DR25D1116Indefinite Delivery Contract
- SPE2DR25D1116-SPE2DR26FTF5WDelivery Order
The Defense Logistics Agency awarded a $7,736.48 delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Ondansetron ODT 8 mg tablets in quantities of 30. This is a firm fixed-price delivery order with an ultimate completion date of December 10, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award represents a non-competitive, non-set-aside procurement executed under an existing contract vehicle. This delivery order is issued against AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical federal medical supply vendor, AmerisourceBergen Drug Corp serves military and veteran healthcare systems through this comprehensive global contract vehicle, which encompasses a broad range of pharmaceutical products, specialty medications, vaccines, and medical supplies across multiple therapeutic domains. The company's extensive federal procurement history demonstrates its established capability to meet DLA medical supply requirements through competitive and non-competitive awards.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.7k | 12/8/25 |